Aimble
Founded
2020
2020
Technologies
AI Companies (Drug Discovery)Developer of an automated drug screening platform designed to predict bound conformations and binding free energies for large libraries of chemicals to the target. The company's automated computing tool offers high-throughput docking solutions, binding affinity prediction solutions, toxicity prediction solutions, and other related services, enabling healthcare professionals to take a proper approach while treating a disease.
Become a Member to view additional information about this company